mode of action of glp 1 agonists The activity GLP-1 and GIP for Type 2 Diabetes and Obesity Mechanisms of action of GLP-1RA.

Gorrini C, Harris IS, Mak TW

Injectable Dose: 0.1 to 0.2 mg three times weekly Topical Option: Apply serum to target areas twice daily Combined Approach: Injectable 3x weekly plus topical to specific areas Duration: 8 to 12 weeks, can extend longer due to favorable safety profile The timing of GHK-Cu introduction matters for maximum benefit

By supporting communication between repair-related cellular pathways and structural protein systems, GHK-Cu continues to serve as a foundational peptide in next-phase research centered around skin quality, follicular support, and connective tissue maintenance

A: Store bottle in cool, dry place with cap tightly closed

Coenzyme Q10 (as ubiquinone) 100 mg